A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
Cells · 09.05.2026 · 15 (10) · 868
DOI: 10.3390/cells15100868 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 09.05.2026. Verfasst von Gallage H D N Ariyaratne und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Medicine, Florida State University, 1115 West Call Street, Tallahassee, FL 32306, USA. Hauptthemen laut MEDLINE: Inflammation, Cardiomyopathies, Arrhythmias, Cardiac, Arrhythmogenic Right Ventricular Dysplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Florida Heart Research Foundation.
Abstract (Originalsprache)
Arrhythmogenic cardiomyopathy (ACM) is a genetic myocardial disorder marked by progressive cardiomyocyte loss, fibro-fatty replacement, ventricular arrhythmias, and risk of sudden cardiac death. Traditionally considered a structural and electrical disease driven by desmosomal dysfunction, emerging evidence redefines ACM as an inflammatory cardiomyopathy in which immune activation plays a central role. This review integrates genetic, molecular, experimental, and clinical data to highlight inflammation as a unifying feature of ACM. Desmosomal gene variants impair cell adhesion and also activate cardiomyocyte-intrinsic inflammatory pathways, including nuclear factor of kappa B (NFκB) and glycogen synthase kinase 3β (GSK3β) signaling, promoting cytokine release, immune cell recruitment, and fibrotic remodeling. Preclinical studies suggest inflammation precedes structural changes, indicating it may be an initiating event rather than a secondary response. Clinical and pathological findings support this model, with inflammatory infiltrates, circulating cytokines, and autoantibodies observed across disease stages. These processes often present as episodic “hot phases” resembling myocarditis, thus complicating diagnosis. The inflammatory landscape involves both innate and adaptive immunity, along with stromal and neuronal remodeling, contributing to arrhythmogenesis through gap junction disruption, calcium-handling abnormalities, and fibrosis. Environmental factors such as exercise, stress, and metabolic disturbances further modulate inflammatory pathways and disease expression. Therapeutically, this evolving perspective supports immunomodulatory approaches, including inhibition of NFκB, GSK3β, and cytokine signaling. Early clinical data on immunosuppressive and cytokine-directed therapies are promising, especially during active inflammatory phases, while gene-based strategies specifically address the underlying genetic defects. In conclusion, ACM should be recognized as an inflammatory cardiomyopathy shaped by interactions between genetic susceptibility and immune dysregulation. Integrating genetic and immunologic profiling may improve diagnosis, risk stratification, and treatment, ultimately leading to refined personalized therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Medicine, Florida State University, 1115 West Call Street, Tallahassee, FL 32306, USA.
- Multidisciplinary Disease Unit for Myocarditis and Arrhythmogenic Cardiomyopathies, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Department of Medicine and Surgery, Vita-Salute San Raffaele University, 20132 Milan, Italy.
ORCID-Profile: Andrea Villatore, Giovanni Peretto, Stephen P Chelko
Förderung
- Florida Heart Research Foundation
Zitieren
APA
Ariyaratne, G. H. D. N., Villatore, A., Peretto, G., & Chelko, S. P. (2026). A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease. Cells, 15(10), 868. https://doi.org/10.3390/cells15100868
Vancouver
Ariyaratne GHDN, Villatore A, Peretto G, Chelko SP. A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease. Cells. 2026;15(10):868. doi:10.3390/cells15100868
BibTeX
@article{Ariyaratne2026,
author = {Ariyaratne, Gallage H D N and Villatore, Andrea and Peretto, Giovanni and Chelko, Stephen P},
title = {A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease},
journal = {Cells},
year = {2026},
volume = {15},
number = {10},
pages = {868},
doi = {10.3390/cells15100868}
}
EUVIMED